Zacks.com users have recently been watching Hologic (HOLX) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Lower sales of COVID-19 assays and supply chain challenges drag Hologic's (HOLX) top line down.
Hologic CEO Steve Macmillan joins 'Closing Bell' to discuss the company's earnings bump, the unprecedented strength in demand for Hologic products and managing costs through Covid.
Hologic, Inc. (NASDAQ:HOLX ) Q4 2022 Earnings Conference Call October 31, 2022 4:30 PM ET Company Participants Ryan Simon - VP, IR Stephen MacMillan - Chairman, President and CEO Karleen Oberton - CFO
Hologic (HOLX) delivered earnings and revenue surprises of 32.26% and 9.98%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
Shares of Hologic Inc. HOLX, +1.30% jumped 7.5% after hours on Monday after the maker of medical equipment and technology reported better-than-expected fiscal fourth-quarter results and issued some fi
Hologic's (HOLX) Molecular Diagnostics sales are likely to have been affected by the significant drop in demand for COVID-19 testing.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.
Want to put an S&P 500 investor in a good mood during earnings season? A huge earnings surprise would do it.

What's Happening With Hologic Stock?

11:00am, Wednesday, 12'th Oct 2022
Hologic stock (NASDAQ: HOLX), a medical devices company focused on women's health, has seen a 19% fall this year, faring slightly better than the broader S&P500 index, down 24%.
Hologic (HOLX) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
MARLBOROUGH, Mass.--(BUSINESS WIRE)---- $HOLX #earnings--Hologic to Announce Financial Results for the Fourth Quarter of Fiscal 2022 on Monday, October 31, 2022

Hologic CEO on supply chain challenges

07:32pm, Monday, 03'rd Oct 2022
Cramer spoke with Hologic CEO Steve MacMillan on Monday.
Hologic (HOLX) has received quite a bit of attention from Zacks.com users lately. Therefore, it is wise to be aware of the facts that can impact the stock's prospects.

Hologic (HOLX) Stock Sinks As Market Gains: What You Should Know

09:45pm, Wednesday, 14'th Sep 2022 Zacks Investment Research
Hologic (HOLX) closed the most recent trading day at $67.99, moving -0.04% from the previous trading session.
Click to get the best stock tips daily for free!

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE